Patient Medication Information: uses, side effects, how to take - Pemazyre
What is PEMAZYRE™ used for?
For the following indication, PEMAZYRE™ has been approved with conditions (NOC/c). This means it has passed Health Canada’s review and can be bought and sold in Canada, but the manufacturer has agreed to complete more studies to make sure the drug works the way it should. For more information, talk to your healthcare professional. PEMAZYRE™ is used to treat adults with a type of cancer called cholangiocarcinoma (bile duct caner) when it:
A test will be done to find out if the cancer has an FGFR2 gene abnormality. This is to make sure that PEMAZYRE™ is right for you. |
What is a Notice of Compliance with Conditions (NOC/c)?
A Notice of Compliance with Conditions (NOC/c) is a type of approval to sell a drug in Canada. Health Canada only gives an NOC/c to a drug that treats, prevents, or helps identify a serious or life-threatening illness. The drug must show promising proof that it works well, is of high quality, and is reasonably safe. Also, the drug must either respond to a serious medical need in Canada, or be much safer than existing treatments. Drug makers must agree in writing to clearly state on the label that the drug was given an NOC/c, to complete more testing to make sure the drug works the way it should, to actively monitor the drug’s performance after it has been sold, and to report their findings to Health Canada. |
How does PEMAZYRE™ work?
Fibroblast growth factor receptors (FGFRs) are proteins found on cells. These help cells grow and divide. Some people with bile duct cancer have FGFRs that are more active than normal. PEMAZYRE™ works by blocking the activity of FGFRs. This should slow down the growth and spread of bile duct cancer cells.
What are the ingredients in PEMAZYRE™?
Medicinal ingredients: pemigatinib
Non-medicinal ingredients: magnesium stearate, microcrystalline cellulose, sodium starch glycolate
PEMAZYRE™ comes in the following dosage forms:
Tablets, 4.5 mg, 9 mg, and 13.5 mg
Do not use PEMAZYRE™ if:
- you are allergic to pemigatinib or to any of the other ingredients in PEMAZYRE™ including any part of the container.
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take PEMAZYRE™. Talk about any health conditions or problems you may have, including if you:
- have problems swallowing tablets
- have severe liver problems
- have severe kidney problems
Other warnings you should know about:
Treatment with PEMAZYRE™ can cause serious side effects, including:
Hyperphosphatemia (high phosphate levels in your blood) or hypophosphatemia (low levels of phosphate in your blood): Your healthcare professional will do blood tests to check levels of phosphate in your blood. These tests will be done 14 days after you start PEMAZYRE™. They will be repeated about every 6 weeks. If your levels are too high or too low, you may need to:
- change the amount of phosphate you eat in your diet;
- change your dose of PEMAZYRE™, or
- start or stop taking other medications that affect the amount of phosphate in your blood.
Because of the risk for hyperphosphatemia, avoid using antacids that contain calcium and supplements that are phosphate-based.
- High levels of creatinine in your blood, which may be a sign that you are having kidney problems.
Eye and vision problems, including:
- dry eye. If this happens you may need to use artificial tears or something similar.
- inflamed eyes (including inflammation of the cornea, which is the front part of the eye)
- increased tears
- serous retinal detachment. This is when fluid builds up in the eye and causes the retina to detach. Your healthcare professional will check your eyes and vision before you start taking PEMAZYRE™, every 2 months for the first 6 months of your treatment and then every 3 months thereafter. If you develop any changes in your vision during your treatment with PEMAZYRE™ such as: blurred vision, flashes of light, or seeing black spots, tell your healthcare professional. You may need to see an eye specialist (an ophthalmologist) right away.
See the Serious Side Effects and What To Do About Them table, below, for more information on these and other serious side effects.
Female patients – Pregnancy and breastfeeding:
- If you are pregnant, or are still able to get pregnant and / or breastfeed, there are specific risks you must discuss with your healthcare professional.
- You should not be pregnant while you are taking PEMAZYRE™. It may harm your unborn baby or make you lose the pregnancy.
For females who are able to get pregnant:
- Your healthcare professional will do a pregnancy test before you start treatment with PEMAZYRE™.
- Use effective birth control during your treatment with PEMAZYRE™ and for 1 month after your last dose. Talk to your healthcare professional about available birth control methods.
- If, during your treatment, you become pregnant or think you are pregnant, tell your healthcare professional right away.
- It is not known if PEMAZYRE™ passes into breastmilk. Do not breastfeed while you are taking PEMAZYRE™ and for 1 month after your last dose. Talk to your healthcare professional about the best way to feed your baby during this time.
Male patients – Pregnancy:
- Use effective birth control each time you have sex with a woman who can get pregnant. This is necessary during your treatment with PEMAZYRE™ and for 1 month after your last dose.
- If, during your treatment, your partner thinks she is pregnant, tell your healthcare professional right away.
Driving and using machines: Before you do tasks which may require special attention, wait until you know how you respond to PEMAZYRE™. If you experience vision problems, do not drive or use tools or machines until the side effect goes away.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
The following may interact with PEMAZYRE™:
- Medicines to treat fungal infections called itraconazole and oral ketoconazole.
- Medicines to treat infections called clarithromycin and erythromycin.
- A medicine to treat HIV infection called efavirenz.
- A medicine to treat high blood pressure or chest pain called diltiazem.
- A medicine to treat tuberculosis or other bacterial infections called rifampin.
- An herbal remedy mainly used to treat depression called St. John’s Wort.
Do not eat or drink grapefruit products or products that contain grapefruit extract during your treatment with PEMAZYRE™. These can affect the way the medicine works.
How to take PEMAZYRE™:
- Take exactly as your healthcare professional tells you. Check with your doctor or pharmacist if you are not sure.
Take one tablet with or without food, once per day, at about the same time each day.
- Take your PEMAZYRE™ every day for 14 days (2-weeks) in a row. This is followed by 7 days (1-week) with no treatment (treatment-free week). Two weeks of treatment and one week with no treatment make up a 21-day cycle.
- Swallow tablets whole. Do not crush, chew, split or dissolve tablet
Usual dose: 13.5 mg per day for 14 days followed by 7 days with no treatment.
You may receive a lower dose if you are taking certain medications or have severe kidney or liver problems.
Your healthcare professional may change your dose of PEMAZYRE™, or may temporarily or completely stop your treatment. This may happen if you develop certain side effects or your disease gets worse.
Overdose:
| If you think you, or a person you are caring for, have taken too much PEMAZYRE™, contact a healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms. |
Missed Dose:
If it is 4 or more hours later than when you should have taken your PEMAZYRE™ dose, or if you vomit after taking your dose:
- do NOT make up the dose. Skip it and continue with your next dose at the usual time. Do not take an extra dose the next day to make up for the missed dose.
If it is less than 4 hours later than when you should have taken your dose, take it as soon as you remember. Continue with your next dose at the usual time.
What are possible side effects from using PEMAZYRE™?
These are not all the possible side effects you may feel when taking PEMAZYRE™. If you experience any side effects not listed here, contact your healthcare professional.
- hair loss
- abnormal hair growth
- feeling tired
dizziness
- headache
- nose bleeds
- fever
- decreased appetite
- taste changes
- heartburn or indigestion
- dry mouth
- mouth sores
- nausea
- vomiting
constipation
- diarrhea
- abdominal pain
- back pain
- pain in the arms or legs
- muscle pain and stiffness
- swelling of the arms and legs
- weight decreased
PEMAZYRETM can cause abnormal blood test results. Your healthcare professional will do blood tests during your treatment and will interpret the results.
Serious side effects and what to do about them
| Symptom / effect | Talk to your healthcare professional | Stop taking drug and get immediate medical help | |
|---|---|---|---|
| Only if severe | In all cases | ||
| VERY COMMON | |||
| Hyperphosphatemia (high blood phosphate levels): muscle cramps and tingling | ✓ | ||
| Hypophosphatemia (low blood phosphate levels): muscle weakness and pain, confusion, seizures, tea-coloured urine, heart or breathing problems | ✓ | ||
| Nail or skin problems: nails separating from the bed; nail pain, breaking of the nails, infected skin around the nails; color or texture changes, dry skin | ✓ | ||
| Palmar-Plantar erythrodysaesthesia (hand-foot syndrome): swelling, peeling or tenderness, mainly on the hands and feet | ✓ | ||
| Arthralgia: joint pain | ✓ | ||
| Urinary tract infection (infection of the urinary system): pain or burning sensation while urinating, frequent urination, blood in the urine | ✓ | ||
Serious side effects and what to do about them
| Symptom / effect | Talk to your healthcare professional | Stop taking drug and get immediate medical help |
|---|
| Only if severe | In all cases | ||
|---|---|---|---|
| Dehydration: feeling thirsty, infrequent urination, feeling dizzy or tired, dark yellow urine, dry mouth and lips | ✓ | ||
| Hypercalcemia (high blood calcium levels): increase in urine production, increase in thirst, nausea, weakness, confusion | ✓ | ||
| Anemia (decreased number of red blood cells): fatigue, weakness, loss of energy, fast heart rate, pale complexion, shortness of breath | ✓ | ||
| Hyponatremia (low blood sodium levels): nausea, vomiting, fatigue, headache, confusion, seizure | ✓ | ||
| COMMON | |||
| Vision problems including serous retinal detachment (when fluid builds up under the retina): blurred vision, black spots, flashes of light, inflammation of the cornea, dry eye | ✓ | ||
| Trichiasis: eyelashes grow inward to the eye | ✓ | ||
| Kidney problems: passing low amounts of urine, nausea, swelling in legs and ankles, confusion, difficulty breathing | ✓ | ||
| Cholangitis (infection of the biliary tract): abdominal pain, fever, chills, jaundice (yellowing of the skin or whites of the eyes), nausea, vomiting | ✓ | ||
| Pleural effusion (a buildup of fluid between the tissues that line the lungs | ✓ | ||
Serious side effects and what to do about them
| Symptom / effect | Talk to your healthcare professional | Stop taking drug and get immediate medical help |
|---|
| Only if severe | In all cases | ||
|---|---|---|---|
| Failure to thrive (a decline in adults, often associated with physical frailty, functional disability, and /or neuropsychiatric impairment): weight loss, weakness, decreased physical activity, difficulty in performing self-care, change in mental status | ✓ | ||
| Sepsis (a serious condition caused by infection and the body’s response to infection potentially leading to organ dysfunction): low blood pressure, fast heart rate, fever, decrease in urination, difficulty breathing, altered mental status. | ✓ | ||
| Intestinal obstruction (an interruption to the flow of the intestines): abdominal pain or distention, nausea, vomiting | ✓ | ||
| Bile duct obstruction (blockage of the bile duct that transports bile from the liver to the gallbladder and small intestine): abdominal pain, dark urine, fever, itching, jaundice (yellowing of the skin or whites of the eyes,) nausea, vomiting, pale colored stools | ✓ | ||
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
Reporting Side Effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. |
Storage:
Store PEMAZYRE™ between 15°C to 30°C.
Keep out of sight and reach of children.
If you want more information about PEMAZYRE™:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; the manufacturer’s website (www.incytebiosciences.ca), or by calling 1-833-309-2759.
Wilmington, Delaware 19803 USA
